
The promising results from clinical studies on the use of viral vectors to address important medical needs have spurred interest in developing scalable and cost-efficient manufacturing processes. Here, we present a case study from a biomanufacturer developing a process for adenovirus oncolytic adenovirus production. The
case study describes a process from upstream cell culture to downstream purification, using scalable modern tools and technologies.